fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

WCLC 2018: NELSON – CT screening saves lives

Written by | 17 Oct 2018

A randomised, controlled screening trial for lung cancer involving almost 16,000 people in the Netherlands and Belgium found that CT screening produced a 26% reduction in lung cancer… read more.

WCLC 2018: Highlights

Written by | 17 Oct 2018

The IASLC 19th World Conference on Lung Cancer (WCLC) was full of highlights, including 3 plenary abstracts being presented in the New England Journal of Medicine and involvement from… read more.

DDW 2018: Quality of life for IBD patients

Written by | 2 Oct 2018

Inflammatory bowel disease can have a detrimental impact of health-related quality of life, and reducing the physical and psychological disease burden is an important therapeutic target. Patient-reported outcomes… read more.

DDW 2018: Predicting who will get IBD

Written by | 2 Oct 2018

To have a chance of preventing IBD clinicians need to be able to predict who is at risk, based on sensitive and selective risk factors. In a translational… read more.

DDW 2018: Choice in patient management

Written by | 2 Oct 2018

IBD specialists have more treatment options than ever before; yet the optimal use of many agents, old as well as new, remains to be defined. A plenary session… read more.

DDW 2018: Treatment of perianal fistulising disease

Written by | 2 Oct 2018

Perianal fistulas remain a debilitating complication for CD patients, with high levels of morbidity and impact on quality of life. Several abstracts and posters at DDW 2018 addressed… read more.

DDW 2018: IBD Study Updates

Written by | 2 Oct 2018

This article summarises some of the key study updates presented at DDW 2018.

ASCO 2018: Synchronous primary lung cancers

Written by | 20 Aug 2018

Professor John Lafrate (Harvard Medical School, Boston) and Professor Frank Detterbeck (Yale School of Medicine, New Haven) spoke in a session looking at some of the difficulties with diagnosis and… read more.

ASCO 2018: KEYNOTE-042 shows OS

Written by | 20 Aug 2018

First-line treatment with the PD-1 inhibitor pembrolizumab showed an overall survival benefit compared to platinum-based chemotherapy in patients with locally advanced or metastatic non-small cell lung cancer and… read more.

ASCO 2018: Choices for front-line NSCLC

Written by | 20 Aug 2018

With permutations of potential front-line treatments for non-small cell lung cancer (NSCLC) seemingly endless, one thing seems certain…

ASCO 2018: Hot topics in lung cancer

Written by | 20 Aug 2018

Hot topics in lung cancer – interviews from ASCO 2018.

ASCO Highlights

Written by | 20 Aug 2018

June 2018 saw the launch of our first edition of LungCancer.Med, a new congress news e-journal containing interviews with speakers and delegates as well as articles on the latest hot… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.